These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 827648)

  • 1. [Value of fractionation in diabetology therapy and particularly for glibenclamide].
    Tutin M
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():345-7. PubMed ID: 827648
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of glibenclamide in different forms of diabetes mellitus].
    Vasiukova EA; Pisarskaia IV; Granovskaia-Tsvetkova AM; Sharova IuA
    Sov Med; 1973 Dec; 36(12):56-9. PubMed ID: 4205164
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary clinical experiences and problems of long-term therapy of diabetes mellitus using 2nd generation sulfonylurea derivatives (glibenclamide)].
    Schilling I; Bruns W; Haller H; Mehnert E; Mohnike A; Jutzi E; Schliack V; Schulze J
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:149-5. PubMed ID: 4200337
    [No Abstract]   [Full Text] [Related]  

  • 4. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Postiglione F; Verdoliva A; Schiraldi F
    Clin Ter; 1974 Jul; 70(2):147-51. PubMed ID: 4212848
    [No Abstract]   [Full Text] [Related]  

  • 5. [Insulin plus sulphonyl-urea compounds in the treatment of diabetes mellitus of the maturity-onset type (author's transl)].
    Traumann KJ; Hösl W; Grom E; Wittemann G
    Dtsch Med Wochenschr; 1982 Feb; 107(5):180-4. PubMed ID: 6799267
    [No Abstract]   [Full Text] [Related]  

  • 6. [Attempts at substituting glibenclamide for insulin in the treatment of diabetes].
    Rojszykowa E
    Pol Tyg Lek; 1972 Dec; 27(49):1941-3. PubMed ID: 4630281
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glibenclamide-insulin combination in the management of secondary failure of sulfonyl-urea medication].
    Hamelbeck H; Klein W; Zoltobrocki M; Schöffling K
    Dtsch Med Wochenschr; 1982 Oct; 107(42):1581-3. PubMed ID: 6813094
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of glibenclamide in the treatment of diabetes mellitus].
    de Pupo AA; da Rocha DM
    Rev Paul Med; 1971 Jun; 77(6):247-50. PubMed ID: 5006000
    [No Abstract]   [Full Text] [Related]  

  • 9. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P; Mughini L
    Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with glibenclamide in long-term treatment of diabetes mellitus.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):237-41. PubMed ID: 813962
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experience with glibenclamide, a new hypoglycemic agent].
    Ser I
    Harefuah; 1971 Oct; 81(8):364-8. PubMed ID: 5005924
    [No Abstract]   [Full Text] [Related]  

  • 12. [HB 419 (glibenclamide) and possibilities of its combinations in the treatment of diabetes mellitus].
    Stratmann FW
    Dtsch Med J; 1970 Jan; 21(2):83-7. PubMed ID: 5001692
    [No Abstract]   [Full Text] [Related]  

  • 13. [Practical viewpoints on the treatment of diabetes with glibenclamide].
    Wadman B; Werner I
    Lakartidningen; 1972 Sep; 69(37):4084-6. PubMed ID: 4627109
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined intravenous glucose-glibenclamide load as test for prediction of success of oral longtime therapy of adult diabetes with glibenclamide].
    Raptis S; Schröder KE; Pfeiffer EF
    Verh Dtsch Ges Inn Med; 1973; 79():1210-3. PubMed ID: 4208214
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs.
    Mohan V; Snehalatha C; Ramachandran A; Viswanathan M
    J Assoc Physicians India; 1990 Aug; 38(8):537-41. PubMed ID: 2123183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modern oral sugar-reducing drugs: focus to glibenclamide].
    Ushakova EA
    Ter Arkh; 2007; 79(12):86-90. PubMed ID: 18220041
    [No Abstract]   [Full Text] [Related]  

  • 17. Longterm clinical study with glibenclamide.
    Solanki SV; Yajnik VH; Shah SS; Shah DP
    J Assoc Physicians India; 1973 Jan; 21(1):1-9. PubMed ID: 4209374
    [No Abstract]   [Full Text] [Related]  

  • 18. The scope of oral glibenclamide in the non-ketotic young diabetics.
    Ram BK; Ahuja MM
    Indian J Med Sci; 1973 Jun; 27(6):435-9. PubMed ID: 4202053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of serum insulin in the double intravenous glucose tolerance test in diabetics before and during glibenclamide therapy].
    Niklas L; Wiederhold K; Otto H
    Verh Dtsch Ges Inn Med; 1971; 77():546-50. PubMed ID: 5005530
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with a new hypoglycemic agent, glibenclamide, HB 419 (Daonil) in diabetes mellitus.
    Ser I
    Isr J Med Sci; 1972 Jun; 8(6):887. PubMed ID: 4626318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.